The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Reading Rheum: Lumbar Spinal Stenosis

Reading Rheum: Lumbar Spinal Stenosis

June 1, 2008 • By David G. Borenstein, MD; Maripat Corr, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

So what are busy clinicians going to recommend to their spinal stenosis patients?1 I think clinicians need to explain the nonsurgical and surgical options to patients. Patients who are younger, with no associated joint disease, with single-level stenosis, and without spondylolisthesis who want surgery have a good opportunity to improve with surgical intervention. Patients who chose medical therapy may be more symptomatic for a period of time, but will become better over the subsequent two years.

You Might Also Like
  • Nonsurgical Management of Lumbar Spinal Stenosis
  • Meet the Lumbar Spinal Stenosis Challenge
  • ACR Makes Available Spinal Stenosis Fact Sheet
Explore This Issue
June 2008

Reference

  1. Malmivaara A, Slatis P, Heliovaara M, et al. Surgical or nonoperative treatment for lumbar spinal stenosis? A randomized controlled trial. Spine. 2007;32:1-8.

 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

IMMUNOLOGY

Potential New Model to study immunological disturbances

By Maripat Corr, MD

Yang YG, Lindahl T, Barnes DE. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell. 2007;131:873-886.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Abstract

Trex1 is the major 3’ DNA exonuclease in mammalian cells, and mutations in the human TREX1 gene can cause Aicardi-Goutières syndrome, characterized by perturbed immunity. Similarly, Trex1(-/-) mice have an autoinflammatory phenotype; however, the mechanism of Trex1-deficient disease is unknown. We report that Trex1, ordinarily associated with the endoplasmic reticulum (ER), relocalizes to the S phase nucleus after gamma irradiation or hydroxyurea treatment. Notably, Trex1-deficient cells show defective G1/S transition and chronic ATM-dependent checkpoint activation, even in the absence of exogenous stress, correlating with persistent single-stranded DNA molecules produced in S phase, which accumulate in the ER. Our data indicate that Trex1 acts on a single-stranded DNA polynucleotide species generated from processing of aberrant replication intermediates to attenuate DNA damage checkpoint signaling and prevent pathological immune activation.

Commentary

In 1984, two French pediatric neurologists—Jean Aicardi and Francoise Goutières—described, in a Portuguese family, a rare neurological condition that is attracting attention as a model to study immunological disturbances in autoimmunity. This condition, Aicardi-Goutières syndrome (AGS), shows autosomal recessive inheritance and is characterized by encephalopathy with elevated lymphocytes in the cerebrospinal fluid, calcification of the basal ganglia, and white matter demyelination.1 In infancy, AGS typically manifests as progressive microcephaly, spasticity, dystonia, and psychomotor retardation. However, AGS is a heterogenous disorder and phenotypic variability includes patients with apparently static or slowly progressive disease, sometimes presenting after several months of normal development.

Recently, mutations in TREX1 and in the genes encoding the three nonallelic components of the RNASEH2 protein complex have been identified in AGS.2-4 TREX1 encodes the major 3’->5’ DNA repair exonuclease in mammalian cells, DNase III/TREX1. Several monoallelic mutations in TREX1 have recently been described in individuals with systemic lupus erythematosus and familial chilblain lupus.5 Despite these known clinical associations, the mechanisms by which TREX1-deficiency promotes disease have remained obscure. In an important new study, Yang et al. describe the accumulation of cytoplasmic single stranded (ss) DNA that is associated with this defect in cell cycle modulation, which could provide a link between this deficiency and chronic inflammation.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Research Reviews Tagged With: NEJM, Research, Spinal Stenosis, surgery, TreatmentIssue: June 2008

You Might Also Like:
  • Nonsurgical Management of Lumbar Spinal Stenosis
  • Meet the Lumbar Spinal Stenosis Challenge
  • ACR Makes Available Spinal Stenosis Fact Sheet
  • The Complexity of Lumbar Spinal Stenosis

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.